Connect with us

Coronavirus (Covid-19)

Singapore to begin human trial of potential Covid-19 prophylactic

Jack Burton

Published 

 on 

Singapore to begin human trial of potential Covid-19 prophylactic | The Thaiger
PHOTO: Straits Times
  • follow us in feedly

A new drug, currently known as TY027, might be used to protect frontline healthcare workers against potential exposure to Covid-19, or travellers when they head to countries with high community transmission. Next week, 23 volunteers in Singapore will be involved in a clinical safety trial for the prophylactic antibody drug, which could be a viable treatment the disease that has already killed more than 400,000 around the globe.

The co-founder of Tychan, the biotech company behind the drug, told the media that if trials are successful, it could be used to render temporary protection against infection, as antibody drugs tend to be effective for about 2-3 weeks per dose. Using the drug to treat confirmed cases “could reduce a lot of problems we face right now,” such as the limited number of ventilators available at hospitals.

“One obvious thing is that a lot of the patients get sick for a very long time, and some of them even get very severe respiratory disease, so much so that you need oxygen ventilators to help them tie through this critical period, without which they would die. We hope this treatment will reduce the number of people who go into such a severe stage, and hopefully the number of people who die from Covid-19 can be kept to a minimum.”

But he noted that the eventual use of the drug, and who it will be administered to, will depend on the outcome of the Phase 1 clinical safety trial, which will take about 6 weeks. Singapore’s Health Sciences Authority granted approval for the trial on Monday. The trial, which will be conducted by SingHealth’s investigational medicine unit, will focus on evaluating the safety, tolerability and “pharmacokinetics,” the way the body reacts to the drug. If proven safe the drug will still have to undergo more tests before it can be used in real-life clinical settings, and that process could take months.

This is the first time an in-human trial for a Covid-19 treatment has been approved in Singapore. Presently, there is no proven antibody-based treatment for Covid-19, nor any licensed vaccine.

Tychan said in a statement that it produced the antibody on February 25, in partnership with Singpore’s Ministry of Defence, the Ministry of Health, the Economic Development Board and other government agencies as part of a whole-of-government collaborative effort. The company then identified it as the most promising among several antibodies that demonstrated 100% neutralisation against Covid-19. Since then, preclinical safety studies and other regulatory requirements, including a 3 week stability test, have been completed successfully.

SOURCE: SOURCE: Bangkok Post

Keep in contact with The Thaiger by following our Facebook page.



Find more SE Asian News courtesy of The Thaiger.

Broke? Find employment in Southeast Asia with JobCute Thailand. Rich? Invest in real estate across Asia with FazWaz Property Group. Even book medical procedures worldwide with MyMediTravel, all powered by DB Ventures.

Jack Burton is an American writer, broadcaster, linguist and journalist who has lived in Asia since 1987. A native of the state of Georgia, he attended the The University of Georgia's Henry Grady School of Journalism, which hands out journalism's prestigious Peabody Awards. His works have appeared in The China Post, The South China Morning Post, The International Herald Tribune and many magazines throughout Asia and the world. He is fluent in Mandarin and has appeared on television and radio for decades in Taiwan, Mainland China, Hong Kong and Macau.

1 Comment

1 Comment

  1. Avatar

    Kelvin

    June 11, 2020 at 11:59 am

    the question is how is this stuff made

    seems like they are all rushing to market at the expense of man kind

    we need to know more before they let the genie out

Leave a Reply

Your email address will not be published. Required fields are marked *

Coronavirus (Covid-19)

Human trials of locally made Covid-19 vaccine to begin in October

Jack Burton

Published

on

Human trials of locally made Covid-19 vaccine to begin in October | The Thaiger
PHOTO: Thailand Business News

Surpassing earlier predictions that human trials of a locally manufactured Covid-19 vaccine could begin as early as the end of the year, Thailand will conduct the first human trials of its vaccine candidate in October, after trials on monkeys produced satisfactory results, with high level of immunity being detected in the animals. The minister for higher education, science, research and innovation made the announcement in a Facebook post today. He says the next step is to recruit volunteers in August and September for human trials of the mRNA vaccine, which was jointly developed by the Vaccine Research Centre of Chulalongkorn […]

Continue Reading

Coronavirus (Covid-19)

Poll shows most Thais still oppose foreign arrivals

Jack Burton

Published

on

Poll shows most Thais still oppose foreign arrivals | The Thaiger
PHOTO: New Straits Times

A recent survey carried out by the National Institute of Development Administration, or Nida Poll, shows that a majority of Thais still oppose opening the country to foreigners, even if they’re not infected with Covid-19, saying the global coronavirus situation is still very serious. The poll was conducted on July 6-8 on 1,251 people aged 18 and over, of various education levels and occupations throughout the country. A “medical and wellness” program would open the country to foreigners who test negative for Covid-19 to receive medical treatment. They would undergo a mandatory 14 day quarantine before being allowed to return […]

Continue Reading

Coronavirus (Covid-19)

Travel bubbles may be postponed “indefinitely”

Jack Burton

Published

on

Travel bubbles may be postponed “indefinitely” | The Thaiger
FILE PHOTO

The Civil Aviation Authority of Thailand now says the proposed “travel bubble” scheme, which could have allowed limited numbers of tourist arrivals from designated “low risk” countries, may have to be “postponed indefinitely”, after its 3 target partners – China, Japan and South Korea – experienced new outbreaks of Covid-19. On Tuesday, the CAAT’s director-general told reporters he expected Thailand to start exchanging tourists in August with countries that had controlled their coronavirus epidemics as Thailand has. But while negotiations have begun, new outbreaks in Beijing, Tokyo and outside Seoul now mean “we probably will have to postpone indefinitely.” He […]

Continue Reading

Trending